Rogers Corp. Sells Shares: How to Decide If You Sell
A senior Rogers Corp. executive sold 830 shares for about $113,000, sparking questions about what it means for the st...
What Happens To Target Date Funds At Retirement
At retirement, target date funds typically rebalance toward conservative assets, adjusting to support withdrawals while aiming to preserve principal.
20,347 articles
Here Wednesday’s Best Wall Street Analyst Calls Hit Markets
A wave of fresh research notes on Abbott Laboratories, Circle Internet, Dow, Kratos Defense, Lockheed Martin, Salesfo...
C3.ai Shares Plunge. Should Investors Consider Buying?
C3.ai saw a sharp drop after its latest results, renewing debate about whether the stock is a value play or a value t...
Piper Sandler Hikes Cloudflare Target to $250 Amid Dip
Piper Sandler lifts Cloudflare’s target to $250 despite a double-digit after-hours fall, arguing the core growth stor...
Stock Price Prediction: Strong Outlook Lifts AMD Target
Analysts push higher targets for AMD as data center AI demand accelerates. A stock price prediction: strong consensus...
Despite Production Guidance, Lucid Faces a Long Road Ahead
Lucid has set a production target, but many investors wonder if the pace will match the plan. This deep dive explains...
Trade Desk Hit Again: HSBC Downgrades to Reduce Target
HSBC downgraded Trade Desk to Reduce with a $20 target, joining a wave of caution as ad-tech faces a shift toward ret...
Wall Street Analyst Believes Palantir Could Double in a Year
Palantir has volatile days, but one wall street analyst believes the stock could double within a year. This article b...
Wall Street Pulls Back on Novo Nordisk and Jefferies
Stocks retreat as Novo Nordisk and Jefferies face analyst downgrades, while Talkspace advances toward a private-equit...
Canaccord Raises C3.ai Price Target as Siebel Becomes CEO
Canaccord Genuity raised its price target on C3.ai to $8 from $7 after Tom Siebel returned as CEO, amid preliminary Q...
Where Will Companies' Stock Be in One Year? TJX Case Study
Investors often wonder where will companies' stock head in a year. This article builds a clear, practical framework t...
Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status